Treatment interventions for Parkinson's disease: an evidence based assessment

被引:188
作者
Rascol, O [1 ]
Goetz, C
Koller, W
Poewe, W
Sampaio, C
机构
[1] Toulouse Univ Hosp, Clin Invest Ctr, F-31073 Toulouse, France
[2] Toulouse Univ Hosp, Dept Clin Pharmacol, INSERM, U455, F-31073 Toulouse, France
[3] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[4] Univ Miami, Dept Neurol, Miami, FL 33152 USA
[5] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[6] Fac Med Lisbon, Inst Pharmacol & Therapeut, Lisbon, Portugal
关键词
D O I
10.1016/S0140-6736(02)08520-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We did a systematic review, with a uniform method of assessment of efficacy and safety, to assess the different interventions available for the management of Parkinson's disease (drugs, surgical interventions, and physical treatments) with respect to the following Indications: prevention of disease progression, symptomatic treatment of motor features (parkinsonism), symptomatic control of motor complications, prevention of motor complications, and symptomatic treatment of non-motor features. Our aim was not to define practice guidelines, but rather to improve clinicians' knowledge of the presently available published clinical evidence, based mainly on randomised controlled trials. We hope that our review will help doctors to incorporate this background into their own decision-making strategy to make appropriate choices with respect to the treatment of individual patients with Parkinson's disease.
引用
收藏
页码:1589 / 1598
页数:10
相关论文
共 104 条
  • [1] Ropinirole for the treatment of early Parkinson's disease
    Adler, CH
    Sethi, KD
    Hauser, RA
    Davis, TL
    Hammerstad, JP
    Bertoni, J
    Taylor, RL
    SanchezRamos, J
    OBrien, CF
    [J]. NEUROLOGY, 1997, 49 (02) : 393 - 399
  • [2] Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa
    Adler, CH
    Singer, C
    O'Brien, C
    Hauser, RA
    Lew, MF
    Marek, KL
    Dorflinger, E
    Pedder, S
    Deptula, D
    Yoo, K
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1089 - 1095
  • [3] Agid Y, 1999, MOVEMENT DISORD, V14, P38
  • [4] Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease
    Allain, H
    Destée, A
    Petit, H
    Patay, M
    Schück, S
    Bentué-Ferrer, D
    Le Cavorzin, P
    [J]. EUROPEAN NEUROLOGY, 2000, 44 (01) : 22 - 30
  • [5] ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210
  • [6] [Anonymous], 1996, Ann Neurol, V39, P29
  • [7] Pergolide monotherapy in the treatment of early PD -: A randomized, controlled study
    Barone, P
    Bravi, D
    Bermejo-Pareja, F
    Marconi, R
    Kulisevsky, J
    Malagù, S
    Weiser, R
    Rost, N
    [J]. NEUROLOGY, 1999, 53 (03) : 573 - 579
  • [8] Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients:: results of a multicentre, randomized, double-blind, placebo-controlled study
    Bergamasco, B
    Frattola, L
    Muratorio, A
    Piccoli, F
    Mailland, F
    Parnetti, L
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (06): : 372 - 380
  • [9] Björklund A, 2000, NOVART FDN SYMP, V231, P7
  • [10] Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease - A multicenter 5-year study
    Block, G
    Liss, C
    Reines, S
    Irr, J
    Nibbelink, D
    Aarli, J
    Aguilar, M
    Ahrens, S
    Bakheit, A
    Baumel, B
    Bertoni, J
    Capildeo, R
    CastroCaldas, A
    Deza, L
    Donaldson, I
    Franck, G
    Fusillo, J
    Gauthier, S
    Gershanik, O
    Granerus, AK
    Hauser, RA
    Hennessey, K
    Hutton, JT
    Joffe, R
    Koller, W
    Last, B
    LeWitt, P
    Mamoli, B
    Manyam, B
    Mark, M
    Nakano, K
    Nausieda, P
    Otero, E
    Paulson, G
    Pinter, M
    Reich, S
    Rodnitzky, R
    Sage, J
    Sampaio, C
    Smith, B
    Teravainen, H
    Tetrud, J
    Tolosa, E
    Ulm, G
    Valesco, F
    [J]. EUROPEAN NEUROLOGY, 1997, 37 (01) : 23 - 27